Analyst Reco. Biogen Inc. Sao Paulo

Equities

Delayed Sao Paulo Other stock markets 11:23:53 2024-07-05 EDT			5-day change	1st Jan Change
206 ^BRL	-2.76%		-4.15%	+0.39%

07-02	US Equities Markets End Higher Tuesday Following Fed Chair Powell's Comments	MT
07-02	Equity Markets Mostly Rise Intraday After Fed Chair Powell's Comments	MT

BIOGEN EXEC SAYS THE ALZHEIMER'S DRUG MARKET "WILL DEVELOP FASTE…	06-12	RE
Wedbush Adjusts Price Target on Biogen to $215 From $219	06-06	MT
Wedbush Raises Biogen Price Target to $219 From $215, Maintains Neutral Rating	05-22	MT
Argus Raises Biogen's Price Target to $250 From $240	05-15	MT
Redburn Atlantic Adjusts Price Target on Biogen to $235 From $275, Keeps Neutral Rating	05-08	MT
HSBC Adjusts Price Target on Biogen to $342 From $339, Maintains Buy Rating	05-03	MT
Guggenheim Adjusts Price Target on Biogen to $255 From $275	04-26	MT
Goldman Sachs Adjusts Biogen Price Target to $340 From $393	04-25	MT
Canaccord Genuity Adjusts Price Target on Biogen to $308 From $305	04-25	MT
Barclays Adjusts Price Target on Biogen to $200 From $215	04-25	MT
HC Wainwright Adjusts Biogen's Price Target to $300 From $325	04-25	MT
Wedbush Adjusts Price Target on Biogen to $215 From $213	04-25	MT
Morgan Stanley Cuts Biogen's Price Target to $331 From $339	04-24	MT
Piper Sandler Raises Biogen's Price Target to $335 From $325	04-24	MT
RBC Lowers Biogen's Price Target to $317 From $326	04-24	MT
Needham Adjusts Price Target on Biogen to $294 From $300	04-19	MT
BMO Capital Adjusts Price Target on Biogen to $260 From $285, Outperform Rating Kept	04-19	MT
Oppenheimer Adjusts Biogen Price Target to $270 From $290	04-19	MT
UBS Adjusts Biogen's Price Target to $214 From $250, Maintains Neutral Rating	04-17	MT
Wedbush Cuts Biogen's Price Target to $213 From $245	04-17	MT

No results for this search